RELAY, Erlotinib Plus Ramucirumab in Untreated, EGFR-Mutated, Metastatic NSCLC: Outcomes by EGFR Exon 19 Deletion Variants
Article in JTO Clinical and Research Reports (December 2023)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Article in JTO Clinical and Research Reports (December 2023)
Article in Thoracic Cancer (September 2023)
Article in Archives of Pathology & Laboratory Medicine (August 2023)